个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
周四盘中交易时段,12只医疗保健类股走势
Gainers
- Venus Concept (NASDAQ:VERO) stock increased by 42.8% to $0.31 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 15.0 million shares, making up 2199.8% of its average full-day volume over the last 100 days. The company's market cap stands at $21.1 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 38.46% to $1.8. Trading volume for NeuroOne Medical Tech's stock is 1.9 million as of 12:30 EST. This is 969.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.1 million.
- Exagen (NASDAQ:XGN) stock increased by 34.8% to $3.44. Exagen's stock is trading at a volume of 343.3K shares as of 12:30 EST. This is 655.8% of its average full-day volume over the last 100 days. The company's market cap stands at $56.0 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 32.5% to $1.59. Trading volume for this security as of 12:30 EST is 42.9 million, which is 2113.5% of its average full-day volume over the last 100 days. The company's market cap stands at $10.3 million.
- Cyclo Therapeutics (NASDAQ:CYTH) shares rose 30.51% to $1.24. Trading volume for Cyclo Therapeutics's stock is 324.4K as of 12:30 EST. This is 853.9% of its average full-day volume over the last 100 days. The company's market cap stands at $10.5 million.
- Apyx Medical (NASDAQ:APYX) shares increased by 22.85% to $1.72. Trading volume for this security as of 12:30 EST is 423.8K, which is 146.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.5 million.
Losers
- Biolase (NASDAQ:BIOL) stock declined by 39.5% to $0.97 during Thursday's regular session. As of 12:30 EST, Biolase's stock is trading at a volume of 2.7 million, which is 8162.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.9 million.
- Prenetics Global (NASDAQ:PRE) shares declined by 23.78% to $1.72. Prenetics Global's stock is trading at a volume of 507.6K shares as of 12:30 EST. This is 1525.2% of its average full-day volume over the last 100 days. The company's market cap stands at $190.3 million.
- C4 Therapeutics (NASDAQ:CCCC) stock decreased by 16.64% to $7.82. As of 12:30 EST, this security is trading at a volume of 301.7K shares, making up 66.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $382.8 million.
- Aytu BioPharma (NASDAQ:AYTU) stock fell 13.02% to $0.19. Aytu BioPharma's stock is trading at a volume of 2.9 million shares as of 12:30 EST. This is 288.6% of its average full-day volume over the last 100 days. The company's market cap stands at $11.9 million.
- GlucoTrack (NASDAQ:GCTK) stock fell 12.44% to $1.62. The company's market cap stands at $25.0 million.
- Ampio Pharmaceuticals (AMEX:AMPE) stock declined by 12.07% to $0.44. Trading volume for this security as of 12:30 EST is 304.2K, which is 63.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.6 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- Venus Concept (NASDAQ:VERO) stock increased by 42.8% to $0.31 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 15.0 million shares, making up 2199.8% of its average full-day volume over the last 100 days. The company's market cap stands at $21.1 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 38.46% to $1.8. Trading volume for NeuroOne Medical Tech's stock is 1.9 million as of 12:30 EST. This is 969.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.1 million.
- Exagen (NASDAQ:XGN) stock increased by 34.8% to $3.44. Exagen's stock is trading at a volume of 343.3K shares as of 12:30 EST. This is 655.8% of its average full-day volume over the last 100 days. The company's market cap stands at $56.0 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 32.5% to $1.59. Trading volume for this security as of 12:30 EST is 42.9 million, which is 2113.5% of its average full-day volume over the last 100 days. The company's market cap stands at $10.3 million.
- Cyclo Therapeutics (NASDAQ:CYTH) shares rose 30.51% to $1.24. Trading volume for Cyclo Therapeutics's stock is 324.4K as of 12:30 EST. This is 853.9% of its average full-day volume over the last 100 days. The company's market cap stands at $10.5 million.
- Apyx Medical (NASDAQ:APYX) shares increased by 22.85% to $1.72. Trading volume for this security as of 12:30 EST is 423.8K, which is 146.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.5 million.
- 金星概念 纳斯达克股票代码:VERO)的股价在周四的例会上上涨了42.8%,至0.31美元。截至美国东部标准时间 12:30,该证券的交易量为1,500万股,占其过去100天平均全日交易量的2199.8%。该公司的市值为2,110万美元。
- NeuroOne 医疗技术 纳斯达克股票代码:NMTC)的股票上涨了38.46%,至1.8美元。截至美国东部标准时间 12:30,NeuroOne Medical Tech股票的交易量为190万股。这是其过去 100 天平均全日交易量的969.0%。他们已发行股票的市值为2910万美元。
- Exagen 纳斯达克股票代码:XGN)的股票上涨了34.8%,至3.44美元。截至美国东部标准时间 12:30,Exagen的股票交易量为343.3万股。这是其过去 100 天平均全日交易量的655.8%。该公司的市值为5,600万美元。
- 纽罗博制药 纳斯达克股票代码:NRBO)股价上涨32.5%,至1.59美元。截至美国东部标准时间 12:30,该证券的交易量为4,290万,占其过去100天平均全日交易量的2113.5%。该公司的市值为1,030万美元。
- Cyclo Therap 纳斯达克股票代码:CYTH)股价上涨30.51%,至1.24美元。截至美国东部标准时间 12:30,Cyclo Therapeutics股票的交易量为324.4万。这是其过去 100 天平均全日交易量的853.9%。该公司的市值为1,050万美元。
- Apyx Medical 纳斯达克股票代码:APYX)的股价上涨了22.85%,至1.72美元。截至美国东部标准时间 12:30,该证券的交易量为423.8K,占其过去100天平均全日交易量的146.8%。他们已发行股票的市值为5,950万美元。
Losers
失败者
- Biolase (NASDAQ:BIOL) stock declined by 39.5% to $0.97 during Thursday's regular session. As of 12:30 EST, Biolase's stock is trading at a volume of 2.7 million, which is 8162.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.9 million.
- Prenetics Global (NASDAQ:PRE) shares declined by 23.78% to $1.72. Prenetics Global's stock is trading at a volume of 507.6K shares as of 12:30 EST. This is 1525.2% of its average full-day volume over the last 100 days. The company's market cap stands at $190.3 million.
- C4 Therapeutics (NASDAQ:CCCC) stock decreased by 16.64% to $7.82. As of 12:30 EST, this security is trading at a volume of 301.7K shares, making up 66.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $382.8 million.
- Aytu BioPharma (NASDAQ:AYTU) stock fell 13.02% to $0.19. Aytu BioPharma's stock is trading at a volume of 2.9 million shares as of 12:30 EST. This is 288.6% of its average full-day volume over the last 100 days. The company's market cap stands at $11.9 million.
- GlucoTrack (NASDAQ:GCTK) stock fell 12.44% to $1.62. The company's market cap stands at $25.0 million.
- Ampio Pharmaceuticals (AMEX:AMPE) stock declined by 12.07% to $0.44. Trading volume for this security as of 12:30 EST is 304.2K, which is 63.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.6 million. See Also:
- Biolase 纳斯达克股票代码:BIOL)股价在周四的例行交易中下跌了39.5%,至0.97美元。截至美国东部标准时间 12:30,Biolase的股票交易量为270万股,占其过去100天平均全日交易量的8162.3%。他们已发行股票的市值为690万美元。
- Prenetics 全球 纳斯达克股票代码:PRE)股价下跌23.78%,至1.72美元。截至美国东部标准时间 12:30,Prenetics Global的股票交易量为507.6万股。这是其过去 100 天平均全日交易量的1525.2%。该公司的市值为1.903亿美元。
- C4 治疗学 纳斯达克股票代码:CCCC)的股票下跌了16.64%,至7.82美元。截至美国东部标准时间 12:30,该证券的交易量为301.7万股,占其过去100天平均全日交易量的66.1%。他们已发行股票的市值为3.828亿美元。
- Aytu 生物制药 纳斯达克股票代码:AYTU)股价下跌13.02%,至0.19美元。截至美国东部标准时间 12:30,Aytu BioPharma的股票交易量为290万股。这是其过去 100 天平均全日交易量的288.6%。该公司的市值为1190万美元。
- GlucoTrac 纳斯达克股票代码:GCTK)股价下跌12.44%,至1.62美元。该公司的市值为2500万美元。
- 安皮奥制药 (AMEX: AMPE)的股票下跌了12.07%,至0.44美元。截至美国东部标准时间 12:30,该证券的交易量为304.2万,占其过去100天平均全日交易量的63.7%。他们已发行股票的市值为660万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!